Dronabinol, due to alternative drugs being more effective, is rarely used for prevention of nausea and vomiting secondary to chemotherapy.
True
False
Combining dronabinol with phenothiazine drugs:
Synergistic antiemetic effects.
Increased adverse effects associated with each drug.
Both
Neither
Adverse effect category/categories:
CNS effects
Autonomic effects
Both
Neither
Nabilone (Cesamet): recently approved in the USA tetrahydrocannabinol derivative.
True
False
Autonomic side effect(s) associated with dronabinol administration:
Hypertension
Conjunctival infection
Bradycardia
A & B
B & C
A & C
A, B & C
Dronabinol:
mechanism of action: stimulation of the CB1 cannabinoid receptor subtype localized:
Around in in the chemoreceptor trigger zone (CTC)
Associated with the emetic center
Both
Neither
Following single dosing and given first-pass metabolism, systemic availability:
5%
10%-20%
40%
50%-60%
Dronabinol administration is associated with a large volume of distribution. This large volume of distribution suggests:
Following a single dose of dronabinol, metabolites are likely undetectable after 1-2 days.
Following a single dose of dronabinol, metabolites are likely detectable for a few weeks.
Under circumstances in which other antiemetic drugs are not efficacious a given patient, dronabinol may be a useful preventative agent in individuals receiving cancer chemotherapy.
True
False
Nabilone is an appropriate prophylactic agent for patients undergoing chemotherapy if other antiemetic drugs are not working.
True
False
Adverse effects associated with nabilone
administration are surprisingly different from that observed with dronabinol.